EPA:ALEMG - Euronext Paris - Matif - FR0000075343 - Common Stock - Currency: EUR
EPA:ALEMG (6/17/2025, 7:00:00 PM)
4.08
-0.11 (-2.63%)
The current stock price of ALEMG.PA is 4.08 EUR. In the past year, price decreased by -1.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 27.85 | 200.12B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 68.27 | 161.49B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 67.52 | 159.71B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 37.94 | 130.78B | ||
2M6.DE | MEDTRONIC PLC | 15.79 | 96.22B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.15 | 51.36B | ||
BOX.DE | BECTON DICKINSON AND CO | 12.19 | 42.56B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 28.51 | 37.63B | ||
DC4.DE | DEXCOM INC | 50.15 | 28.12B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 14.18 | 18.40B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 14.18 | 18.39B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 13.97 | 18.13B |
Laboratoires Euromedis SA specializes in the design, manufacturing, and distribution of medical equipment. The company is headquartered in Neuilly-Sous-Clermont, Hauts-De-France and currently employs 54 full-time employees. The company went IPO on 2000-03-27. The firm specializes in the manufacturing, import, and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The company also leases the equipment and provides home maintenance and hospitalization services. through a network of outlets under the Paramat name.
LABORATOIRES EUROMEDIS
ZA de la Tuilerie
Neuilly-sous-Clermont HAUTS-DE-FRANCE FR
Employees: 54
Phone: 33344738360
The current stock price of ALEMG.PA is 4.08 EUR. The price decreased by -2.63% in the last trading session.
The exchange symbol of LABORATOIRES EUROMEDIS is ALEMG and it is listed on the Euronext Paris - Matif exchange.
ALEMG.PA stock is listed on the Euronext Paris - Matif exchange.
LABORATOIRES EUROMEDIS (ALEMG.PA) has a market capitalization of 11.71M EUR. This makes ALEMG.PA a Nano Cap stock.
LABORATOIRES EUROMEDIS (ALEMG.PA) currently has 54 employees.
LABORATOIRES EUROMEDIS (ALEMG.PA) has a support level at 3.95 and a resistance level at 4.16. Check the full technical report for a detailed analysis of ALEMG.PA support and resistance levels.
The Revenue of LABORATOIRES EUROMEDIS (ALEMG.PA) is expected to grow by 7.54% in the next year. Check the estimates tab for more information on the ALEMG.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALEMG.PA does not pay a dividend.
LABORATOIRES EUROMEDIS (ALEMG.PA) will report earnings on 2025-10-27.
LABORATOIRES EUROMEDIS (ALEMG.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.15).
ChartMill assigns a technical rating of 4 / 10 to ALEMG.PA. When comparing the yearly performance of all stocks, ALEMG.PA is a bad performer in the overall market: 61.02% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ALEMG.PA. ALEMG.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ALEMG.PA reported a non-GAAP Earnings per Share(EPS) of -2.15. The EPS decreased by -178.48% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 24.05% | ||
ROA | 27.66% | ||
ROE | 57.02% | ||
Debt/Equity | 0.41 |
ChartMill assigns a Buy % Consensus number of 37% to ALEMG.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 8.35% and a revenue growth 7.54% for ALEMG.PA